Aurora Cannabis Inc. - Common Shares (ACB)

Curaleaf's unsolicited $272 million tender offer for Aurora Cannabis targets EU-GMP cultivation capacity, with Aurora's board forming a special committee to evaluate the cash-and-stock bid.

Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry.

Aurora Cannabis would expand Curaleaf's international presence, but it hasn't been a strong business in recent years.

German market expansion drove $43M in international medical cannabis revenue amid Canadian pricing pressure.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Aurora Cannabis (NASDAQ:ACB) said shareholders approved all items presented at its annual general meeting, including setting the board size at five directors, electing the company’s nominees, reappointing Ernst & Young LLP as auditor, and approving its non-binding advisory vote on executive comp

Aurora Cannabis (NASDAQ:ACB) reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following reimbursement changes and the company’s planned exit from lower-margin Canadian consumer cannabis op

Aurora (ACB) Q4 2026 Earnings Transcript

Aurora Cannabis (NASDAQ:ACB) reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as Canadian medical reimbursement changes weigh on revenue and margins. Executive Chairman and CEO Miguel

The cannabis stock has lost around 96% of its value over the past five years.

Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026 results. The company posted net revenue of $207 million, a figure driven by a stunning recovery in its beverage segment and explosive growth in

In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the company delivered a "record" revenue performance of $206.7 million, outstripping analyst estimates of $201.3 million, it fell significantly

Is it finally time to consider this beaten-down stock?

Aurora Cannabis (ACB) Q3 2026 Earnings Transcript

Don't get your hopes up.

The marijuana business just got a little easier in America -- and maybe a whole lot more profitable.

Washington D.C. – December 12, 2025 – In a move sending seismic waves through the financial markets, President Donald Trump is reportedly poised to enact a landmark reclassification of marijuana, shifting it from a Schedule I to a Schedule III controlled substance under federal law. The news, which broke late on

If weed becomes legal, will Aurora Cannabis become profitable?

Rigetti's November plunge erased October's gains and then some. Is the quantum computing stock a buy in this sudden dip?

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.